Shionogi agrees to end Japanese cefcapene patent disputes
This article was originally published in Scrip
Executive Summary
Shionogi has decided to reach settlements with two companies in Japan that it had taken legal action against over what it saw as the infringement of a patent for the crystal form of its oral cephalosporin Flomox (cefcapene pivoxil).